Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
about
Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer.Baseline neutrophil-lymphocyte ratio is associated with baseline and subsequent presence of brain metastases in advanced non-small-cell lung cancerEGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer.Correction: Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.Baseline and On-Treatment Characteristics of Serum Tumor Markers in Stage IV Oncogene-Addicted Adenocarcinoma of the Lung.Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.
P2860
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Serum Biomarkers Associated wi ...... V Non-Small Cell Lung Cancers.
@ast
Serum Biomarkers Associated wi ...... V Non-Small Cell Lung Cancers.
@en
type
label
Serum Biomarkers Associated wi ...... V Non-Small Cell Lung Cancers.
@ast
Serum Biomarkers Associated wi ...... V Non-Small Cell Lung Cancers.
@en
prefLabel
Serum Biomarkers Associated wi ...... V Non-Small Cell Lung Cancers.
@ast
Serum Biomarkers Associated wi ...... V Non-Small Cell Lung Cancers.
@en
P2093
P2860
P50
P1433
P1476
Serum Biomarkers Associated wi ...... V Non-Small Cell Lung Cancers.
@en
P2093
Camelia Sima
Christopher G Azzoli
Helena A Yu
Jarushka Naidoo
Mariza Daras
Martin Fleisher
Melissa L Johnson
P2860
P304
P356
10.1371/JOURNAL.PONE.0146063
P407
P577
2016-01-05T00:00:00Z